Sale!

NPC2 Gene Niemann-Pick Disease Type C2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NPC2 Gene Niemann-Pick Disease Type C2 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NPC2 gene, which are responsible for Niemann-Pick disease type C2 (NPC2). This condition is a rare, genetic lysosomal storage disorder characterized by the accumulation of lipids in various tissues, including the brain, liver, and spleen, leading to neurological dysfunction and other systemic symptoms. Early detection through genetic testing can be crucial for management and treatment options.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the NPC2 gene to identify any genetic mutations associated with the disease. With a cost of 4400 AED, the test is aimed at individuals with a family history of Niemann-Pick disease or those exhibiting symptoms related to the disorder, providing them with crucial information for potential treatment plans and lifestyle adjustments. DNA Labs UAE employs state-of-the-art technology and expertise to ensure accurate and reliable test results, contributing significantly to the understanding and management of this rare condition.

Description

NPC2 Gene Niemann-Pick disease type C2 Genetic Test

Test Name: NPC2 Gene Niemann-Pick disease type C2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for NPC2 Gene Niemann-Pick disease type C2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Niemann-Pick disease type C2.

Test Details: The NPC2 gene is associated with Niemann-Pick disease type C2 (NPC2), which is a rare genetic disorder characterized by the accumulation of lipids (fatty substances) in various organs of the body. The NPC2 gene provides instructions for producing a protein that is involved in the transport and processing of cholesterol and other lipids within cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of NPC2, NGS genetic testing can identify mutations or variations in the NPC2 gene that may be responsible for causing or contributing to the development of Niemann-Pick disease type C2.

NGS genetic testing for NPC2 involves obtaining a DNA sample from an individual, usually through a blood or saliva sample. The DNA is then sequenced using NGS technologies to analyze the entire coding region of the NPC2 gene, as well as potentially other genes associated with similar conditions. The sequencing data is then analyzed and compared to a reference sequence to identify any genetic variants or mutations that may be present.

The results of the NGS genetic test for NPC2 can help in confirming a diagnosis of Niemann-Pick disease type C2 and determining the specific genetic cause of the condition in an individual. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options or clinical management.

Test Name	NPC2 Gene Niemann-Pick disease type C2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for NPC2 Gene Niemann-Pick disease type C2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Niemann-Pick disease type C2
Test Details	The NPC2 gene is associated with Niemann-Pick disease type C2 (NPC2), which is a rare genetic disorder characterized by the accumulation of lipids (fatty substances) in various organs of the body. The NPC2 gene provides instructions for producing a protein that is involved in the transport and processing of cholesterol and other lipids within cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of NPC2, NGS genetic testing can identify mutations or variations in the NPC2 gene that may be responsible for causing or contributing to the development of Niemann-Pick disease type C2. NGS genetic testing for NPC2 involves obtaining a DNA sample from an individual, usually through a blood or saliva sample. The DNA is then sequenced using NGS technologies to analyze the entire coding region of the NPC2 gene, as well as potentially other genes associated with similar conditions. The sequencing data is then analyzed and compared to a reference sequence to identify any genetic variants or mutations that may be present. The results of the NGS genetic test for NPC2 can help in confirming a diagnosis of Niemann-Pick disease type C2 and determining the specific genetic cause of the condition in an individual. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options or clinical management.